Abstract
Rationale and objectives
Dopamine (DA) agonists reliably disrupt prepulse inhibition (PPI) of the startle reflex in animals but less so in humans despite cross-species similarities in the neural regulation of PPI. This study examines whether individual variation in baseline PPI may account for the inconsistencies in DA agonist-induced PPI disruption in humans.
Methods
Baseline PPI measures were obtained from 32 healthy adult men. Subjects were subsequently tested in three sessions after ingestion of placebo or active drug in a balanced double-blind design. Seventeen subjects were given 0.05 and 0.1 mg of pergolide (a direct DA agonist) and 15 subjects were given 100 and 200 mg of amantadine (an indirect DA agonist). In each treatment group, subjects were assigned to “high” and “low” PPI subgroups based on the median split of their baseline PPI.
Results
Amantadine and pergolide disrupted PPI in high- but not in low-PPI subjects. In contrast, low-PPI subjects showed a trend towards PPI facilitation especially with pergolide.
Conclusions
Our results suggest that baseline PPI is an important determinant of the effect of DA agonists on PPI.
Similar content being viewed by others
References
Abduljawad KAJ, Langley RW, Bradshaw CM, Szabadi E (1998) Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. J Psychopharmacol 12:239–245
Abduljawad KAJ, Langley RW, Bradshaw CM, Szabadi E (1999) Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man. J Psychopharmacol 13:3–9
Blumenthal TD (1996) Inhibition of the human startle response is affected by both prepulse intensity and eliciting stimulus intensity. Biol Psychol 44:85–104
Blumenthal TD (1997) Prepulse inhibition decreases as startle reactivity habituates. Psychophysiology 34:446–450
Bond AJ, Lader MH (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47:211–218
Braff DL, Geyer MA (1990) Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 47:181–188
Braff DL, Stone C, Callaway E, Geyer MA, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339–343
Braff DL, Grillon C, Geyer MA (1992) Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206–215
Braff DL, Swerdlow NR, Geyer MA (1999) Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry 156:596–602
Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patients groups, and pharmacological studies. Psychopharmacology 156:234–258
British Medical Association and Royal Pharmaceutical Society of Great Britain (2005) British National Formulary, 49th edn. British Medical Association and Royal Pharmaceutical Society of Great Britain, London
Broersen LM, Feldon J, Weike I (1999) Dissociative effects of apomorphine infusions into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition and amphetamine-induced locomotion. Neuroscience 94:39–46
Bubser M, Koch M (1994) Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions in the medial prefrontal cortex. Psychopharmacology 113:487–492
Ellenbroek BA, Budde S, Cools AR (1996) Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience 75:535–542
Factor SA (1999) Dopamine agonists. Med Clin North Am 83:415–443
Geyer MA, Krebs-Thompson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117–154
Hamm AO, Weike AI, Schuoo HT (2001) The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues. Psychopharmacology 156:259–265
Hardman JG, Limbird LE, Goodman Gilman A (2001) The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York
Hazlett EA, Buchsbaum MS, Tang CY, Fleischman MB, Wei TC, Byne W, Haznedar MM (2001) Thalamic activation during an attention-to-prepulse startle modification paradigm: a functional MRI study. Biol Psychiatry 50:281–291
Heimans RL, Rand MJ, Fennesy MR (1972) Effects of amantadine on uptake and release of dopamine by a particulate fraction of rat basal ganglia. J Pharm Pharmacol 24:875–879
Hutchison KE, Swift R (1999) Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology 143:394–400
Koch M, Schnitzler HU (1997) The acoustic startle response in rats—circuits mediating evocation, inhibition and potentiation. Behav Brain Res 89:35–49
Kumari V, Gray JA (1999) Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology 141:11–15
Kumari V, Gray JA, Geyer MA, Ffytche D, Soni W, Mitterschiffthaler MT, Vythelingum GN, Simmons A, Williams SC, Sharma T (2003) Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects. Psychiatry Res 122:99–113
Lacroix L, Broersen LM, Feldon J, Weiner I (2000) Effects of local infusions of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition, prepulse inhibition amphetamine-induced activity. Behav Brain Res 107:111–121
Langtry HD, Clissold SP (1990) Pergolide. A review of its pharmacological properties and therapeutic potential in Parkinson's disease. Drugs 39:491–506
Mansbach RS, Geyer MA, Braff DL (1988) Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology 94:507–514
Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100:6186–6191
Nomikos GG, Iurlo M, Andersson JL, Kimura K, Svensson TH (1994) Systemic administration of amperozide, a new atypical antipsychotic drug, preferentially increases dopamine release in the rat medial prefrontal cortex. Psychopharmacology 115:147–156
Norris H (1971) The action of sedation on brain-stem oculomotor systems in man. Neuropharmacology 10:181–191
Schwarzkopf S, McCoy L, Smith D, Boutros N (1993) Test–retest reliability of prepulse inhibition of the acoustic startle response. Biol Psychiatry 34:896–900
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33
Spielberger CD (1983) Manual for the state-trait anxiety inventory. Consulting Psychologists Press, Palo Alto
Stoof JC, Booij J, Drukarch B (1992) Amantadine as N-methyl-d-aspartic acid receptor antagonist. New possibilities for therapeutic application? Clin Neurol Neurosurg 94(Suppl):S4–S6
Swerdlow NR, Caine SB, Braff DL, Geyer MA (1992) Neural substrates of sensorimotor gating of the startle reflex: preclinical findings and their implications. J Psychopharmacol 6:176–190
Swerdlow NR, Auerbach P, Monroe SM, Harston H, Geyer MA, Braff DL (1993) Men are more inhibited than women by weak prepulses. Biol Psychiatry 34:253–260
Swerdlow NR, Filion D, Geyer MA, Braff DL (1995) “Normal” personality correlates of sensorimotor, cognitive and visuospatial gating. Biol Psychiatry 37:286–299
Swerdlow NR, Hartman PL, Auerbach PP (1997) Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders. Biol Psychiatry 4:452–460
Swerdlow NR, Taaid N, Oostwegel JL, Randolph E, Geyer MA (1998) Towards a cross-species pharmacology of sensorimotor gating: effects of amantadine, bromocriptine, pergolide and ropinirole on prepulse inhibition of acoustic startle in rats. Behav Pharmacol 9:389–396
Swerdlow NR, Eastvold A, Gerbranda T, Uyan KM, Hartman P, Doan Q, Auerbach P (2000) Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects: impact of caffeine intake and withdrawal. Psychopharmacology 151:368–378
Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P (2001) Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology 158:230–240
Swerdlow NR, Eastvold A, Karban B, Ploum Y, Stephany N, Geyer MA, Cadenhead K, Auerbach PP (2002a) Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies. Psychopharmacology 161:189–201
Swerdlow NR, Stephany N, Shoemaker JM, Ross L, Wasserman LC, Talledo J, Auerbach PP (2002b) Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross-species comparisons. Psychopharmacology 164:82–92
Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Shoemaker J, Auerbach PP (2003) Amphetamine effects on prepulse inhibition across-species: replication and parametric extension. Neuropsychopharmacology 28:640–650
Vollenweider FX, Remensberger S, Hell D, Geyer MA (1999) Opposite effects of 3,4-methylenedioxymethamphetamine (MDMA) on sensorimotor gating in rats versus healthy humans. Psychopharmacology 143:365–372
Weike AI, Bauer U, Hamm AO (2000) Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 47:61–70
Williams GV, Goldman-Rakic PS (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572–575
Zavitsanou K, Cranney J, Richardson R (1999) Dopamine agonists in the orbital prefrontal cortex can reduce prepulse inhibition of the acoustic startle reflex in the rat. Pharmacol Biochem Behav 63:55–61
Acknowledgements
The authors have no conflict of interest or any involvement, financial or otherwise, that might have biased the present work. This project was supported by University of Crete Research Funds Account (E.L.K.E. 1348). The studies reported in this original investigation comply with the current laws of Greece, where they were performed.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bitsios, P., Giakoumaki, S.G. & Frangou, S. The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology 182, 144–152 (2005). https://doi.org/10.1007/s00213-005-0056-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-005-0056-x